TRCT
HUM icon

Tower Research Capital (TRC)’s Humana HUM Stock Holding History

Tower Research Capital (TRC)’s Portfolio HUM Stock Details HUM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$185K Sell
1,069
-1,321
-55% -$271K ﹤0.01% 1682
2025
Q4 		$612K Sell
2,390
-3,074
-56% -$806K 0.01% 732
2025
Q3 		$1.42M Buy
5,464
+4,333
+383% +$1.14M 0.04% 394
2025
Q2 		$277K Sell
1,131
-2,064
-65% -$515K 0.01% 1495
2025
Q1 		$842K Sell
3,195
-3,454
-52% -$934K 0.03% 573
2024
Q4 		$1.69M Sell
6,649
-40
-0.6% -$10.7K 0.03% 416
2024
Q3 		$2.12M Buy
6,689
+674
+11% +$240K 0.06% 266
2024
Q2 		$2.25M Sell
6,015
-563
-9% -$190K 0.04% 388
2024
Q1 		$2.28M Sell
6,578
-12,133
-65% -$4.6M 0.05% 251
2023
Q4 		$8.57M Buy
18,711
+13,209
+240% +$6.51M 0.11% 152
2023
Q3 		$2.68M Buy
5,502
+2,553
+87% +$1.2M 0.08% 232
2023
Q2 		$1.32M Buy
2,949
+1,011
+52% +$509K 0.04% 373
2023
Q1 		$941K Sell
1,938
-865
-31% -$428K 0.03% 478
2022
Q4 		$1.44M Sell
2,803
-9,867
-78% -$5.19M 0.06% 252
2022
Q3 		$6.15M Buy
12,670
+5,583
+79% +$2.72M 0.1% 163
2022
Q2 		$3.32M Sell
7,087
-13,023
-65% -$5.79M 0.07% 222
2022
Q1 		$8.75M Buy
20,110
+10,794
+116% +$4.52M 0.08% 210
2021
Q4 		$4.32M Buy
9,316
+3,930
+73% +$1.74M 0.07% 219
2021
Q3 		$2.1M Buy
5,386
+2,973
+123% +$1.26M 0.05% 258
2021
Q2 		$1.07M Sell
2,413
-9,989
-81% -$4.36M 0.03% 606
2021
Q1 		$5.2M Buy
12,402
+8,256
+199% +$3.3M 0.09% 205
2020
Q4 		$1.7M Buy
4,146
+1,849
+80% +$769K 0.05% 267
2020
Q3 		$951K Buy
2,297
+574
+33% +$231K 0.01% 1054
2020
Q2 		$668K Buy
1,723
+1,156
+204% +$433K 0.03% 786
2020
Q1 		$178K Buy
+567
New +$191K 0.01% 802
2019
Q4 		– Sell
-2,116
Closed -$541K – 3884
2019
Q3 		$541K Sell
2,116
-342
-14% -$95.9K 0.04% 542
2019
Q2 		$652K Buy
2,458
+749
+44% +$190K 0.04% 379
2019
Q1 		$455K Sell
1,709
-6,265
-79% -$1.81M 0.03% 656
2018
Q4 		$2.28M Buy
7,974
+7,799
+4,457% +$2.47M 0.16% 129
2018
Q3 		$59K Sell
175
-2,097
-92% -$681K ﹤0.01% 1661
2018
Q2 		$677K Buy
+2,272
New +$665K 0.04% 508
2018
Q1 		– Sell
-3,952
Closed -$981K – 3512
2017
Q4 		$981K Buy
3,952
+3,898
+7,219% +$963K 0.13% 166
2017
Q3 		$13K Sell
54
-5
-8% -$1.23K ﹤0.01% 2956
2017
Q2 		$14K Sell
59
-1,526
-96% -$345K ﹤0.01% 1415
2017
Q1 		$327K Buy
1,585
+1,534
+3,008% +$317K 0.03% 200
2016
Q4 		$10K Sell
51
-216
-81% -$41.2K ﹤0.01% 2646
2016
Q3 		$47K Buy
267
+156
+141% +$27.1K ﹤0.01% 1179
2016
Q2 		$20K Buy
111
+1
+0.9% +$178 ﹤0.01% 2229
2016
Q1 		$20K Sell
110
-337
-75% -$58.5K ﹤0.01% 1344
2015
Q4 		$80K Sell
447
-57
-11% -$10K 0.01% 369
2015
Q3 		$90K Buy
+504
New +$93.2K 0.01% 619
2015
Q2 		– Sell
-450
Closed -$83.5K – 4659
2015
Q1 		$80K Sell
450
-150
-25% -$23.7K 0.01% 1082
2014
Q4 		$86K Sell
600
-4,319
-88% -$590K 0.01% 762
2014
Q3 		$641K Buy
4,919
+4,403
+853% +$560K 0.07% 207
2014
Q2 		$66K Sell
516
-1,982
-79% -$235K 0.01% 1118
2014
Q1 		$282K Buy
2,498
+600
+32% +$62.5K 0.04% 318
2013
Q4 		$196K Sell
1,898
-441
-19% -$43.2K 0.03% 527
2013
Q3 		$218K Buy
+2,339
New +$215K 0.02% 693

Other funds holding HUM

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Eagle Capital Management (New York)
Eagle Capital Management (New York) New York $29.8B AUM 12.13% 1-Year Est. Return

Tower Research Capital (TRC)'s HUM Position: Q1 2026 in Review

Tower Research Capital (TRC) reduced its Humana (HUM) stake by 55% in Q1 2026, selling an estimated $271K and leaving 1,069 shares worth $185K. The position accounts for ﹤0.01% of the portfolio, ranked #1682.

Tower Research Capital (TRC) first reported a position in HUM in Q3 2013 and has held it in 48 quarters since. The position peaked at $8.75M in Q1 2022. 779 funds tracked by Wall St. Rank hold HUM as of Q1 2026.

  • Tower Research Capital (TRC) held 1,069 shares of Humana worth $185K as of Q1 2026.
  • Tower Research Capital (TRC) sold 1,321 Humana shares in Q1 2026, an estimated $271K.
  • Humana made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #1682 holding.
  • Tower Research Capital (TRC) first reported a position in Humana in Q3 2013 and has held it in 48 quarters since.
  • Tower Research Capital (TRC)'s Humana position peaked at $8.75M in Q1 2022.
  • 779 funds tracked by Wall St. Rank held Humana as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.